Sign in
4

Changes in Ownership

TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-19-019332

EVP, North America Commercial sold 738 shares at $15.67 ($11,568)

  • EVP, North America Commercial acquired 738 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

O'Grady Brendan P. · EVP, North America Commercial

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-03-12 Exercise or conversion : show line 1 in the form +738 2,126.49 D
2019-03-12 Sale : show line 2 in the form −738 $15.67 $11,568 1,388.49 D
Open-market sales · 738 sh · avg $15.67 · $11,568

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-03-12 Exercise or conversion : show line 3 in the form Restricted Share Units −738 0 D
Loading xslF345X03/doc4.xml…